Log In
Print this Print this

zafirlukast (Accolate)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionSynthetic, selective peptide leukotriene receptor antagonist
Molecular Target Not available
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAsthma
Indication DetailsTreat and prevent asthma; Treat asthma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today